ReviewArchives of microbiology2026
Engineering Saccharomyces cerevisiae secretory system for recombinant protein production: strategies from signal peptides to protease control.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saccharomyces cerevisiae remains one of the most widely used eukaryotic platforms for recombinant protein production because of its GRAS status, genetic accessibility, and ability to perform post-translational modification. Despite these advantages, secretion of heterologous proteins is frequently limited by inefficient ER folding, trafficking bottlenecks, and proteolytic degradation. This review critically examines both established and emerging strategies aimed at overcoming these barriers, with particular emphasis on signal peptide selection and design, engineering of the early secretory pathway, and control of vacuolar and Golgi-associated proteases. Rather than treating these approaches in isolation, we integrate growing evidence showing that secretion efficiency is governed by coordinated interactions between signal sequences, folding capacity, vesicular transport, and degradation pathways. Recent advances demonstrate that single genetic interventions are rarely sufficient, and that improved secretion outcomes are more consistently achieved through combinatorial strain engineering, fusion-based designs, and pathway-level optimization. Finally, we highlight emerging computational and data-driven tools, including machine learning–guided signal peptide design and predictive models for folding and trafficking bottlenecks, which offer new opportunities for rational host optimization. Together, these insights provide a framework for developing more robust yeast secretion platforms capable of supporting complex recombinant proteins.
Indexed as
Identifiers
42029766What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.